BACKGROUND: Male fertility largely depends on the quality of sperm production, which may be affected by environmental and genetic factors. In this study, we explored a possible role of the polymerase gamma (POLG) gene polymorphism, recently reported to be associated with male infertility in some populations. METHODS: The polymorphic CAG repeat (usually 10 codons long) in the POLG gene was studied in 1298 male subjects: 429 patients with infertility/subfertility, and 869 controls (495 men from the general population with unknown fertility and 374 recent fathers). In all subjects, the POLG polymorphism was assessed in relation to their semen quality, andÐin the fertile controlsÐwith biological fecundity measured as waiting time-to-pregnancy (TTP) for the couples. In the patients lacking the common POLG allele, the outcome of the assisted reproductive techniques (ART) for the couples was evaluated. RESULTS: The absence of one (10/¹10) or both common POLG alleles (¹10/¹10) was more frequent among the subfertile patients than among fertile controls (P = 0.021 and P = 0.04 respectively). The estimated predictive value for infertility in a man homozygous for the POLG polymorphism was 15.5% (95% CI: 4.8±51%). There was a positive association with sperm concentration: 14.3% of the normospermic subfertile patients were homozygous for the absence of the common POLG allele (¹10/¹10), in comparison with 2.3% of unselected controls (P = 0.001) and 0.9% of the fertile men (P = 0.0001). No association with sperm motility, morphology and TTP was found. Spermatozoa of the three ¹10/¹10 patients treated with IVF retained the ability to penetrate the egg, but the fertilization rate was low. Nine homozygous ¹10/¹10 patients were treated with ICSI, resulting in pregnancy in seven couples. CONCLUSIONS: The POLG gene polymorphism should be considered as a possible contributing factor in patients with unexplained subfertility and normal spermiograms. The oocyte penetration ability of sperm may be partially impaired in the ¹10/¹10 patients but most of them can be successfully treated with ICSI.
Introduction
Infertility in humans affects 10±15% of couples;~20% of the cases are attributable solely to the male partner, in a further 25% a subfertile male contributes to the problem, and in~15% no factor can be de®ned in either partner (WHO, 1987; Skakkebñk et al., 1994; Huynh et al., 2002) .
Clinical assessment of male infertility/subfertility is primarily based on the analysis of semen quality. The most informative parameters are sperm concentration and total sperm count, followed by sperm motility and morphology (WHO, 1999) . Sperm concentration exceeding 20 Q 10 6 /ml is usually considered normal, although values up to 40 Q 10 6 /ml have been associated with subfertility (Bonde et al., 1998) . There is also ongoing debate concerning the predictive value of other sperm parameters, such as motility and morphology, for the assessment of fertility potential (Comhaire and Vermeulen, 1995; Zinaman et al., 2000; Guzick et al., 2001; Menkveld et al., 2001) .
Studies of sperm function, especially motility, turned the attention of researchers to the possible role of sperm mitochondria which produce large quantities of energy (Folgero et al., 1993) . Mitochondria have their own genome (mtDNA), which codes for proteins involved in the respiratory chain and oxidative phosphorylation system. Numerous studies indicated an association between different polymorphisms, mutations or deletions in the mitochondrial genome and sperm dysfunction (Lestienne et al., 1997; Ruiz-Pesini et al., 2000; Holyoake et al., 2001; St John et al., 2001; Spiropoulos et al., 2002) . One of these studies (Ruiz-Pesini et al., 2000) was particularly informative as it identi®ed speci®c mtDNA haplogroups that are associated with asthenozoospermia. On the other hand, in one study no association of mtDNA with sperm dysfunction was found (Cummins et al., 1998) , and some recent reports showed an increased mtDNA content in infertile men (Dõ Âez-Sanchez et al., 2003; May-Panloup et al., 2003) .
The key nuclear enzyme involved in the elongation and repair of mtDNA strands is DNA polymerase gamma (POLG), believed to be the only polymerase acting in the mitochondria (Bolden et al., 1977) . The catalytic subunit of POLG is encoded by the POLG gene, which was mapped to chromosome 15q24 and includes a CAG repeat region (Ropp and Copeland, 1996) . A recent investigation of the frequency of different CAG repeat lengths in different European populations showed a high frequency (88%) of 10 codons (Rovio et al., 2001) , indicating that this common allele is maintained by selection. According to that study (Rovio et al., 2001) , the absence of the common allele on both chromosomes (x/x or ¹10/¹10 according to our nomenclature) seems to be associated with male infertility, since it was observed in 3.5±9% of infertile males with impaired sperm quality (after exclusion of azoospermia and severe oligozoospermia), while none of the fertile control individuals was homozygous for the lack of the common allele. These intriguing ®ndings prompted us to examine the polymorphism of the POLG gene among Danish men, whose average sperm counts appear to be low (Andersen et al., 2000; Jùrgensen et al., 2001) . In particular, we were interested in exploring possible associations between the POLG polymorphism and semen quality and fecundity. We report here the results of our analysis of a large series of well characterized patients and controls.
Materials and methods

Studied subjects
Our study series included 1298 males divided into three groups. Infertile (azoospermic) and subfertile (with retained spermatogenesis) patients, nearly all Danish, included 429 males from infertile couples (unable to conceive for at least 1 year), referred to our clinic for an andrological work-up before fertility treatment. All patients were karyotyped and tested for microdeletions of the Y chromosome, and those with genetic abnormalities were excluded.
The fertile control group of 374 Danish subjects was invited to participate in research projects via their female partners. Their fatherhood was not genetically veri®ed. However, these men were recruited to the study by their pregnant spouses, who knew that they would be subjected to genetic studies. Moreover, we have complete hormone and semen quality data on these individuals, and they are consistent with their good reproductive function. These subjects included: (A) 306 men recruited from the antenatal care unit for a study of reproductive health of Danish men (Jùrgensen et al., 2001 ).
Only couples that achieved the pregnancy without any fertility treatment were invited to participate. (B) Sixty-eight healthy men, selected from couples recruited for a prospective study of the association of time-to-pregnancy (TTP) with reproductive variables (Bonde et al., 1998; Jensen et al., 2000; . Only men who achieved fatherhood during the study period (12 months) were included in the current investigation.
The unselected control group of 495 young Danish men from the general population with unknown fertility was recruited for prospective studies of reproductive health in Europe (Jùrgensen et al., 2001; while attending a compulsory medical examination before being considered for military service.
Clinical analysis
All subjects underwent a thorough andrological examination, including a comprehensive analysis of reproductive hormones in serum (testosterone, inhibin B, LH, FSH, oestradiol and sex hormonebinding globulin) and semen analyses. Control subjects donated only one semen sample. The semen analysis was performed as previously described (Bonde et al., 1998; Andersen et al., 2000; Jùrgensen et al., 2001; . Three parameters of sperm quality, concentration, motility and morphology, were used for the statistical analysis of an association with the POLG polymorphism. Sperm concentration was divided into clinical categories de®ned as: azoospermia and severe oligozoospermia, <5 Q 10 6 /ml; moderate oligozoospemia, 5±20 Q 10 6 /ml; and normospermia, >20 Q 10 6 /ml. Motility was assessed according to the WHO guidelines (WHO, 1999) with small modi®cations (Jùrgensen et al., 2001; , and a cut-off value of 50% of motile sperm was used to de®ne normal motility. Sperm morphology was assessed either according to the WHO (Rowe et al., 1993; WHO, 1999) , or using the so-called strict criteria (Menkveld et al., 1990; . In order to compare the data, we chose different normal' cut-off values, according to previous studies of the impact of sperm morphology on fecundity. For the subjects analysed according to the WHO, 21% of normal forms was the lower cut-off value (Menkveld et al., 2001) , 39% the upper threshold (Slama et al., 2002) , and 22±38% was considered the uncertain zone. It was dif®cult to select the cut-off value for the strict criteria, because of some disagreement in the literature. We selected 8% of normal spermatozoa as the lower cut-off value (Guzick et al., 2001) , 19% as the upper threshold (Slama et al., 2002) , and 9±18% as the uncertain zone. In addition, we calculated the median values of spermatozoa with defects of mid-piece (neck) and tail in all studied subjects, which were 8 and 3% respectively, and assessed the distribution of subjects below and above these values.
Molecular analysis of the POLG gene DNA was isolated from peripheral blood samples using a kit (Roche Diagnostics Gmbh, Mannheim, Germany). Two primers (GGTCCCTGCACCAACCATGA and CTTGCCCGAAGATTTGC-TCGT), matching positions 267±286 and 535±553 respectively, of the POLG mRNA (accession number X98093) were used to amplify a 286 bp DNA fragment, using the Pfu DNA polymerase (Stratagene, San Diego, CA). PCR was performed in 30 ml of (®nal concentrations): 12 mmol/l Tris±HCl, pH 8.8; 10 mmol/l KCl; 10 mmol/l (NH 4 )SO 4 , 2.0 mmol/l MgSO 4 ; 0.1% Triton X-100; 0.1 mg/ml BSA; 250 mmol/l dNTP; 30 pmol of each primer and 2 IU Pfu polymerase. PCR conditions were: 98°C for 5 min, 40 cycles of 98°C for 30 s, 63°C for 1 min, 72°C for 1min 45 s and one cycle of 72°C for 5 min. DNA fragments were puri®ed from 1% agarose gels and analysed ®rst by applying a Cy5-labelled sequencing primer (CY5-CTGGATGTC-CAATGGGTTGT, position 494±513) under standard PCR conditions, resulting in a DNA fragment, which was sequenced on an ALF-express sequencer and analysed by the Fragment Analyser software (Amersham-Pharmacia Biotech, Uppsala, Sweden). Next, all bands that differed from a normal CAG 10/10 band (putative ¹10/¹10) were re-analysed by direct sequencing of the fragment, using the same Cy5-labelled primer or a Cy5-labelled primer positioned on the other side of the CAG repeat (CY5-TCGGGCCAGGGCCGGTT, position 323± 339); each DNA fragment was sequenced twice. The positions with heterogeneous base call' were determined and compared with what was expected from the presence of the different combinations of CAG repeat lengths. The two methods were equally sensitive and all those detected by one method were con®rmed using the alternative method.
Statistical analysis
Differences between frequencies were quanti®ed using odds ratios (ORs) and compared using Fisher's exact test. Con®dence intervals (CIs) for prevalences and ORs were exact, i.e. based on the binomial and the non-central hypergeometric distributions respectively. Testing a tendency towards higher prevalences among the groups, taking advantage of their ordinal structure (i.e. increasing fertility), was done with Goodman's gamma test (Goodman and Kruskal, 1979) . A CI for the predictive value of homozygosity for the POLG gene polymorphism was obtained by ®rst expressing it in terms of the ratio of the prevalences of the homozygosity among the fertile and infertile men, and, second, inserting an exact CI for the corresponding OR. The result was con®rmed by a pro®le likelihood approach. Distributions of TTP were compared using a t-test and con®rmed by a Mann±Whitney test and a discrete time Cox model.
Results
Distribution of the POLG alleles among patients and controls CAG repeat lengths ranging from eight to 13 triplets were detected. In concert with the previous report (Rovio et al., 2001) , homozygotes with 10 repeats in both alleles (10/10) were the most common and constituted 75% of all subjects. The following proportions of men in the studied groups had normal haplotypes: 71.8% (95% CI: 67.3±76%) of infertile/ subfertile patients, 73.5% (95% CI: 69.4±77.4%) of healthy young men from the general Danish population (fertility unknown), and 80.7% (95% CI: 76.4±84.6%) of fertile controls (Figure 1) . A highly signi®cant trend (g = 0.15; P = 0.004) towards increasing proportion of the common allele with the increasing fertility was immediately apparent, the OR of having 10/10 relative to the unselected controls was increasing from 0.9 (95% CI: 0.7±1.2) among the patients to 1.5 (95% CI: 1.1±2.1) among fertile controls. The absence of one common allele (heterozygous, 10/¹10) was marginally more frequent among the patients (25.4%, 95% CI: 21.4±29.8%) than among the unselected controls (24.8%, 95% CI: 21.1±28.9%, P = 0.88, not signi®cant) but signi®cantly more frequent than among the fertile controls (18.4%, 95% CI: 14.6±22.8%, P = 0.021). The frequency of the absence of the common POLG allele (¹10/¹10) was very low in all groups: 2.8% (95% CI: 1.5± 4.8%) in the subfertile/infertile group, 0.8% (95% CI: 0.2± 2.3%) in the fertile group, and 1.6% (95% CI: 0.7±3.2%) in our sample of the general population. The frequencies of POLG's CAG ¹10/¹10 in the fertile control group (0.8%) and the subfertile patients (2.8%) were signi®cantly different (3.6, 95% CI: 0.95±20, P = 0.04). Furthermore, the tendency toward a higher frequency of both 10/¹10 and ¹10/¹10 with declining fertility was also signi®cant (g =0.12; P = 0.021, and g = 0.37, P = 0.032 respectively).
Based on the frequencies of double`mutant' haplotypes (CAG ¹10/¹10) among infertile patients (12/428) and fertile controls (3/374), we assessed the predictive value of homozygosity for the POLG gene polymorphism. Assuming that a prevalence of infertility is 5%, the probability that a man, randomly chosen from the general population, is infertile is 5%. If the man is known to be homozygous for the POLG polymorphism, the estimated probability that he is infertile increases to 15.5% (95% CI: 4.8±51%). With an assumed prevalence of infertility of, for example, 7%, the predictive value increases to 20.8% (95% CI: 6.7±60%).
Is there an association between the POLG gene polymorphism and spermatogenesis and semen quality?
The subjects were strati®ed according to sperm concentration and motility (Table I) . Only one patient with POLG's CAG ¹10/¹10 was found in the subgroup with azoospermia or severe oligozoospermia (his mean sperm concentration was 2 Q 10 6 / ml), and only three in the subgroup with moderate oligozoospermia. The proportion of heterozygotes was relatively higher among the infertile/subfertile patients with azoospermia or severe oligozoospermia in comparison with the controls. These low percentages among the controls may be due to chance because of the very small numbers of subjects with severe oligozoospermiaÐas is indicated by the very broad CIs.
Interestingly, we found that 14.3% of those with normospermia and unexplained subfertility were homozygous ¹10/ ¹10, compared with only 2.3% in the unselected control group (P = 0.001) and 0.9% in the fertile group (P = 0.0001). Thus, the OR of having ¹10/¹10 and being normospermic and infertile was 18.1 (95% CI: 3.3±184) in comparison to fertile men.
We did not observe an association of the POLG polymorphism with decreased sperm motility; the majority of subjects either heterozygous or homozygous for the absence of the common allele had reasonably good motility (Table I) . Sperm morphology had to be analysed separately, because two different methods of assessment were used, therefore the data are not included in Table I . We had to analyse the data using different thresholds for different morphological forms. Regardless of how we de®ned the morphology thresholds, we found no association between the POLG polymorphism and sperm morphology.
The analysis of the reproductive hormone pro®le was consistent with the status of spermatogenesis and normal testicular±pituitary axis function in all patients and controls. There was no association between the hormone pro®le and the POLG polymorphism (data not shown).
Analysis of association between the POLG gene polymorphism and fecundity
We then addressed the question whether or not the POLG polymorphism has any association with fertility or fecundity. Most of our fertile controls were young men recruited when they awaited their ®rst child; therefore, it was not possible to associate the distribution of subjects with the POLG polymorphism with the number of children. For all subjects in our fertile control group B we had recorded the waiting TTP during a previous prospective study of factors affecting couple fecundity (Bonde et al., 1998) . In addition, a large proportion of men in the control group A provided retrospective information on TTP in a questionnaire. We used those data to analyse a possible association of TTP with the POLG polymorphism, especially the heterozygotes, since we found only three homozygotes among the fertile controls. The three fertile ¹10/¹10 subjects had normal sperm parameters and reproductive hormones. In the fertile control group A, the male partners with 10/10 reported an average TTP of 3.9 T 0.4 (SE) months, whereas the 10/¹10 men reported a mean TTP of 6.3 T 1.9 months (P = 0.21, not signi®cant). In the fertile control group B, those with 10/10 had a mean TTP of 3.4 T 0.27 months, those with 10/¹10, 2.5 T 0.42 months (P = 0.13, not signi®cant). For both fertile subgroups combined, the mean TTP values were 3.8 T 0.4 months (median 2 months) for the 10/10 subjects versus 5.6 T 1.6 months (median 2 months) for the 10/¹10 subjects (P = 0.26, not signi®cant). Thus, no signi®cant association between the POLG gene polymorphism and TTP was found.
Eleven of the 12 patients homozygous for the POLG polymorphism were treated by assisted reproductive techniques (ART). In four cases a contributing female factor was present, with one exception (case 10, partial tubal occlusion) the problems were negligible. The outcome of the treatment is listed in Table II . Three cases underwent standard IVF. In one couple, three of four oocytes cleaved to an embryo, whereas only one of nine and one of ®ve cleaved in the two other couples. One patient conceived but miscarriaged, two remaining patients conceived after ICSI, but one aborted. Nine of the 11 ART-treated ¹10/¹10 patients underwent ICSI, either as the ®rst treatment or after failed IVF. Apart from a single case, where none of 16 oocytes were fertilized after ICSI (case 4, Table II), all others had fertilization and cleavage. Seven partners conceived and delivered eight healthy children; one couple (case 1) subsequently underwent a second ICSI procedure which resulted in another child.
Discussion
In this large study of infertile/subfertile patients and well characterized controls, we found a high frequency of the absence of the common allele with 10 CAG repeats in the POLG gene in patients with fertility problems, but noteworthy, mainly among those with a truly idiopathic condition, in whom conventional parameters of semen quality were within the normal range. Male subfertility is a heterogeneous disorder and a symptom rather than a disease, because it may be due to a number of underlying systemic and local diseases, both inherited and acquired. In most cases, the pathogenesis involves impairment in sperm production, maturation or function. But in many subfertile patients no problem can be detected by semen analysis. Some of these patients may The proportions are given as percentage and N, 95% CIs are listed underneath. Signi®cant differences in frequencies of the POLG polymorphism between subfertile patients and fertile controls are marked: a P = 0.0106; b P = 0.0009; c P = 0.005; d P = 0.0001 compared with fertile controls.
harbour the POLG gene polymorphism which seems to impair sperm function in a discrete manner, without affecting traditional spermiograms markedly.
In a previous analysis of the POLG polymorphism, Rovio et al. (Rovio et al., 2001) found a substandard motility of spermatozoa in a substantial subset of infertile patients, and hypothesized that the variant POLG might cause some defects in, for example, mtDNA repair or replication, leading to a reduced energy metabolism and impaired motility of spermatozoa. However, we could not corroborate this attractive hypothesis: the surprising ®nding of our study was that the majority (18 of 23) of the subjects homozygous for the POLG polymorphism in our series had sperm motility within the normal range. Depletion and rearrangements of mtDNA, including those caused by mutations in other regions of the POLG gene, are often manifested as serious diseases in humans, e.g. progressive external ophtalmoplegia (Van Goethem et al., 2001; Elpeleg et al., 2002) , whereas variants of POLG limited to the CAG repeats were not associated with any systemic disorders and seem to cause solely an impairment in male fertility (Rovio et al., 1999; this study) . The molecular mechanism of this impairment remains to be elucidated.
We found an association between sperm concentration and the POLG polymorphism, but in the opposite direction than we had expected. Nearly all ¹10/¹10 homozygotes had reasonable sperm counts; most of them, in fact, exceeding the current normal cut-off value of 20 Q 10 6 sperm/ml. Such an association was not observed among the heterozygotes, who were more or less evenly distributed across the sperm concentration strata, except the controls, who were less represented in the subgroup with the lowest sperm counts, most probably because these groups were very small. Rovio et al. (2001) observed a low number of morphologically normal spermatozoa in some patients with ¹10/¹10, but always in conjunction with either poor motility or decreased sperm concentration. We could not con®rm this in our study, and we found no correlation between the POLG polymorphism and sperm motility or morphology. This discrepancy, however, could simply be caused by technical differences between the laboratories. The assessment of these variables, especially morphology, is subjective and not very sensitive, thus discrete differences between the groups cannot be excluded and will require further studies using other methods and parameters of semen quality.
We investigated a possibility that the POLG polymorphism could impair the post-ejaculatory functions of spermatozoa, which include oocyte penetration and fertilization. We had recorded an in vitro sperm penetration test in some patients but we had too few polymorphic subjects to observe any associations. Another marker of biological fecundity is the TTP. We found a weak trend to longer TTPs in the control subjects heterozygous for the POLG polymorphism, but could not substantiate this observation in a more conclusive manner, because of the low number of subjects in this category. However, we had data on the outcome of ART in nearly all homozygous ¹10/¹10 patients. In three cases treated with IVF, cleavage of embryos was obtained, but the oocyte fertilization rate tended to be low, thus we cannot exclude some impairment of the ¹10/¹10 sperm ability to penetrate or fertilize the oocyte. When ICSI was used, fertilization of oocytes did not seem to be impaired, as nearly all couples conceived. So far, all children appear to be healthy.
Finally, this study found a similar distribution of the normal and polymorphic POLG alleles in the Danish population to that reported in several other populations, including Finland (Rovio et al., 1999; . In Finland, semen quality appears to be better than in Denmark and the incidences of genital malformations and testicular cancer are low (Jùrgensen et al., 2001; Toppari et al., 2001 ). The differences in the male reproductive health between the two countries cannot be explained by the clustering of the ¹10/¹10 genotype in Denmark; however, it is theoretically possible that the POLG polymorphism may render spermatozoa more sensitive to certain adverse environmental or lifestyle factors to which the Danish population is exposed.
In conclusion, our study con®rmed an association between the POLG gene polymorphism and male subfertility. The ¹10/ ¹10 patients had better average semen parameters than infertile men in general, thus the POLG gene polymorphism should be considered as a possible contributing factor in cases of idiopathic subfertility with normal spermiograms. Molecular mechanisms leading to the impairment of fertility in patients with this polymorphism remain to be elucidated, but we found that spermatozoa of ¹10/¹10 patients may have a somewhat impaired ability to penetrate or fertilize intact oocytes. This problem can be solved by ICSI and the clinical results of this treatment are promising.
